Rhys Cohen
@rhyscohen.bsky.social
Australian | drug nerd | all things cannabis policy | views are my own
Reposted by Rhys Cohen
New @peningtoninstitute.bsky.social report in today's @theheraldsun.bsky.social on the economic lunacy that is cannabis prohibition. #SpringSt
July 11, 2025 at 12:02 AM
New @peningtoninstitute.bsky.social report in today's @theheraldsun.bsky.social on the economic lunacy that is cannabis prohibition. #SpringSt
NSW Drug Summit recommends the government:
- legislate a medical defence for medicinal cannabis drivers
- enable more than one safe injecting room to operate in the state
- expand access to pharmacotherapies and increase the number of pharmacotherapy prescribers
- legislate a medical defence for medicinal cannabis drivers
- enable more than one safe injecting room to operate in the state
- expand access to pharmacotherapies and increase the number of pharmacotherapy prescribers
April 3, 2025 at 11:20 PM
NSW Drug Summit recommends the government:
- legislate a medical defence for medicinal cannabis drivers
- enable more than one safe injecting room to operate in the state
- expand access to pharmacotherapies and increase the number of pharmacotherapy prescribers
- legislate a medical defence for medicinal cannabis drivers
- enable more than one safe injecting room to operate in the state
- expand access to pharmacotherapies and increase the number of pharmacotherapy prescribers
Reposted by Rhys Cohen
Canada’s legal cannabis shops expanded 13-fold & prices fell 28% during 2019-2023.
My new study checked if those big retail changes were related to usage changes, i.e., after 2018’s initial legalization impact had already passed. 1/6
#EconSky #EpiSky @brocku.bsky.social
doi.org/10.1159/0005...
My new study checked if those big retail changes were related to usage changes, i.e., after 2018’s initial legalization impact had already passed. 1/6
#EconSky #EpiSky @brocku.bsky.social
doi.org/10.1159/0005...
Exploring Associations between Cannabis Prices, Stores, and Usage after Recreational Legalization
Abstract. Introduction: Canada legalized recreational cannabis in October 2018, but commercial retailing took time to develop. This study first explored how self-reported cannabis use prevalence, dail...
doi.org
March 10, 2025 at 2:29 PM
Canada’s legal cannabis shops expanded 13-fold & prices fell 28% during 2019-2023.
My new study checked if those big retail changes were related to usage changes, i.e., after 2018’s initial legalization impact had already passed. 1/6
#EconSky #EpiSky @brocku.bsky.social
doi.org/10.1159/0005...
My new study checked if those big retail changes were related to usage changes, i.e., after 2018’s initial legalization impact had already passed. 1/6
#EconSky #EpiSky @brocku.bsky.social
doi.org/10.1159/0005...
The alleged offences committed by CDA Clinics QLD and Dr Ben Jansen occurred in April 2021. It took the TGA 2.5 years to commence legal action against them.
www.cannabiz.com.au/tga-legal-ac...
www.cannabiz.com.au/tga-legal-ac...
TGA legal action against CDA Clinics Qld hits buffers as Vitura places subsidiary in liquidation
Vitura Health has placed CDA Clinics Qld into liquidation in a move that could force the TGA to drop its legal action against the subsidiary.
www.cannabiz.com.au
January 15, 2025 at 12:05 AM
The alleged offences committed by CDA Clinics QLD and Dr Ben Jansen occurred in April 2021. It took the TGA 2.5 years to commence legal action against them.
www.cannabiz.com.au/tga-legal-ac...
www.cannabiz.com.au/tga-legal-ac...
There is a double-standard applied to assessing the evidence for medicinal cannabis being beneficial or harmful. Evidence of benefit requires robust, comprehensive clinical trials, while evidence of harms requires only anecdotes.
www.cannabiz.com.au/defending-th...
www.cannabiz.com.au/defending-th...
Defending the role of cannabis as a public and community good: the call to action in 2025
After 2024 ended with calls for medicinal cannabis to be removed from the Special Access Scheme, the industry must fight back in 2025.
www.cannabiz.com.au
January 9, 2025 at 11:59 PM
There is a double-standard applied to assessing the evidence for medicinal cannabis being beneficial or harmful. Evidence of benefit requires robust, comprehensive clinical trials, while evidence of harms requires only anecdotes.
www.cannabiz.com.au/defending-th...
www.cannabiz.com.au/defending-th...
The third report in Penington Institute's Cannabis in Australia series is out now – and it reveals the changing public attitudes towards both medicinal and personal use cannabis in Australia.
The 2024 report outlines the latest data, trends and insights, including:
The 2024 report outlines the latest data, trends and insights, including:
November 28, 2024 at 12:19 AM
The third report in Penington Institute's Cannabis in Australia series is out now – and it reveals the changing public attitudes towards both medicinal and personal use cannabis in Australia.
The 2024 report outlines the latest data, trends and insights, including:
The 2024 report outlines the latest data, trends and insights, including: